For patients with ischemic stroke due to large vessel occlusion who undergo mechanical thrombectomy (MT), predictors against re-employment include female sex and persistent functional deficits.
Low-field portable magnetic resonance imaging (pMRI) acquired at low magnetic field strength can detect infarcts in patients with ischemic stroke.
Investigators evaluated the safety and functional outcomes of IV alteplase in patients who have had an acute ischemic stroke and are taking NOACs.
For patients with acute ischemic stroke receiving alteplase, use of non-vitamin K antagonist oral anticoagulants (NOACs) in the previous seven days is not associated with an increased risk for intracranial hemorrhage compared with not using anticoagulants.
Patients with large cerebral vessel occlusion and sizable strokes on imaging have better functional outcomes at 90 days, but more intracranial hemorrhages, with endovascular therapy plus medical care versus medical care alone.
Among patients with a history of ischemic stroke, more intensive low-density lipoprotein cholesterol (LDL-C)-lowering statin-based therapies are associated with a decreased risk for recurrent stroke but an increased risk for hemorrhagic stroke.
About half of patients with COVID-19 with acute ischemic stroke (AIS) have poor outcomes, with 38.8% mortality.
For patients with ischemic stroke, use of tenecteplase (TNK) for thrombolysis is associated with a lower rate of symptomatic intracranial hemorrhage (sICH) than alteplase (ALT).
Although age-standardized stroke burden measures decreased or remained stable from 1990 to 2019 in the United States, the incidence of stroke is increasing among young adults in the South and Midwest.
For young adults (aged 35 years or younger), the incidence of ischemic stroke is higher among women than men.
